-5%
Reglutide Injection/Semaglutide is used to treat adults (aged 18 years and older) with type 2 diabetes when diet and exercise are not enough to control blood sugar levels.
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA): Mimics GLP-1 hormone, stimulating insulin production and reducing blood sugar.
- Approved for over 15 years to treat Type 2 diabetes.
- Acts on brain areas suppressing appetite and inducing a feeling of fullness.
- When combined with diet and exercise, it leads to significant weight loss.
- Studies show significant weight loss, with 15% body weight loss in half of the participants and 20% in nearly a third after 68 weeks.
- Weight tends to be regained after stopping semaglutide
- BMI of 27kg/m2 or greater: with one weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol).
- BMI of 30kg/m2 or greater.
- Consult Primary Care Physician (PCP): Essential for personalized guidance based on medical history.
- For Diabetic Individuals: Discuss acceptable and safe combinations with existing diabetes medications.
